Ibotta Q1 Revenue $82.5M Exceeds Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy IBTA?
Reports Q1 revenue $82.5M, consensus $80.72M. "We started the year with strong operational momentum, delivering first quarter results that exceeded our expectations. This performance was driven by disciplined execution with our core product offering and the continued success of our LiveLift pilots," said Ibotta CEO and Founder, Bryan Leach. "The expansion of the Ibotta Performance Network remains a core priority, and the addition of marquee publishers Uber and Giant Eagle significantly increases our reach across both third-party e-commerce delivery and traditional grocery. We believe the ongoing strengthening of our network and core product offerings has us well-positioned to return to year-over-year growth in the third quarter."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IBTA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IBTA
Wall Street analysts forecast IBTA stock price to fall
6 Analyst Rating
1 Buy
3 Hold
2 Sell
Hold
Current: 36.780
Low
22.00
Averages
28.00
High
33.00
Current: 36.780
Low
22.00
Averages
28.00
High
33.00
About IBTA
Ibotta, Inc. is a technology company that allows consumer packaged goods (CPG) brands to deliver digital promotions to consumers through a single network called the Ibotta Performance Network (IPN). The Company provides promotional services to publishers, retailers, and advertisers through the IPN, which includes its direct-to-consumer mobile, Web, and browser extension properties and its network of third-party publisher properties. The Company offers products in non-discretionary categories, such as grocery, and also works with general merchandise manufacturers in categories such as toys, clothing, beauty, electronics, pets, home goods, and sporting goods. Its technology platform uses an artificial intelligence (AI)-enabled offer engine that is designed to match and distribute the right offer to the right consumer at the right time. The Company also hosts offers on direct-to-consumer properties, which include the Ibotta-branded cashback mobile app, Website, and browser extension.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ibotta Reports Q1 Earnings, Revenue Beats Expectations
- Earnings Performance: Ibotta's Q1 GAAP EPS of -$0.43 misses expectations by $0.12, indicating challenges in profitability that may affect investor confidence.
- Revenue Results: The company reported Q1 revenue of $82.48 million, a 2.5% year-over-year decline, yet it beats market expectations by $1.76 million, suggesting some level of market demand despite difficulties.
- Financial Guidance: For Q2 2026, Ibotta projects revenue between $82 million and $86 million, reflecting a cautious outlook with a year-over-year decrease of 2% at the midpoint, indicating a careful approach to future market conditions.
- Adjusted EBITDA: The expected adjusted EBITDA ranges from $9 million to $12 million, with a midpoint margin of 12.5%, demonstrating the company's efforts in cost control despite overall revenue decline.
See More
Johnson Fistel Investigates Potential Claims Against Hasbro and Others for Fiduciary Breaches
- Hasbro Shareholder Investigation: Johnson Fistel is investigating potential claims against Hasbro (NASDAQ: HAS) executives, as shareholders who held shares before February 7, 2022, may seek corporate governance reforms aimed at enhancing executive oversight and recovering funds, highlighting concerns over corporate governance practices.
- Humana Financial Disclosures: Humana Inc. (NYSE: HUM) shareholders who held shares continuously since July 27, 2022, may pursue governance reforms due to executives allegedly downplaying the impact of rising medical costs on adjusted earnings per share, which poses risks of information asymmetry for investors.
- Ibotta IPO Risks: Ibotta (NYSE: IBTA) failed to disclose significant risks associated with its contract with Kroger during its April 18, 2024 IPO, exposing investors to undisclosed risks and potentially impacting its governance structure reforms.
- Inspire Medical Device Issues: Inspire Medical Systems (NYSE: INSP) shareholders who held shares before August 6, 2024, may seek governance reforms as executives allegedly failed to disclose that demand for the Inspire V device was weaker than expected, leading to a significant reduction in earnings guidance and raising questions about corporate transparency.
See More
Ibotta Extends Strategic Partnership with Denver Nuggets
- Community Investment Commitment: Ibotta's extended strategic partnership with the Denver Nuggets reflects the company's deep emotional ties and investment in the Denver community, further solidifying its influence in the local market.
- Sponsorship Agreement Extension: The partnership includes the sponsorship of the Nuggets' jersey patch, signifying that Ibotta's relationship with the team goes beyond commercial interests to a shared commitment to the city's development.
- Charitable Impact: The 'A Shot for Change' initiative launched in 2023 has raised over $250,000 for local nonprofits, demonstrating Ibotta's active role in supporting the community.
- Employee Engagement: Ibotta employees are actively involved in volunteer activities with the Nuggets, providing groceries for local students, which further strengthens the company's connection with the community.
See More
UBER ENTERS EXCLUSIVE MULTI-YEAR PARTNERSHIP WITH IBOTTA PERFORMANCE NETWORK
Uber's New Partnership: Uber has entered into a multi-year partnership with the IBOtta performance network.
Focus on Performance Marketing: The collaboration aims to enhance Uber's performance marketing strategies through IBOtta's platform.
See More
Ibotta Announces Additional $100 Million Stock Buyback
- Buyback Program Expansion: Ibotta's board has authorized an additional $100 million stock buyback of Class A common stock, building on a previous $300 million repurchase approval, reflecting the company's confidence in its stock value.
- Financial Strength: The strong balance sheet and consistent cash flow generation enable Ibotta to return capital to shareholders while continuing to invest in the Ibotta Performance Network, ensuring effective capital returns.
- No Expiration Limit: The stock repurchase program has no expiration date, allowing for flexible adjustments in timing and amounts based on market conditions and other factors, enhancing the company's capital management flexibility.
- Future Revenue Guidance: Ibotta outlines Q1 2026 revenue guidance of $78 million to $82 million, with transformation driven by LiveLift indicating a positive outlook for the company's growth prospects.
See More
Ibotta Authorizes $100 Million Stock Buyback
- Buyback Program Expansion: Ibotta's Board of Directors has authorized an additional $100 million for the repurchase of Class A common stock, building on a previous $300 million authorization, which reflects the Board's confidence in the company's long-term growth prospects.
- Capital Allocation Strategy: CEO Bryan Leach emphasized that this buyback reflects the company's commitment to a disciplined capital allocation strategy aimed at creating value for shareholders while maintaining a strong balance sheet and consistent cash flow generation.
- Flexible Repurchase Mechanism: The share repurchase program has no expiration date, allowing repurchases to be conducted through open market transactions or privately negotiated deals based on market conditions and legal requirements, ensuring the company can effectively buy back shares while adapting to market changes.
- Forward-Looking Statement Risks: Ibotta cautions investors about the risks and uncertainties associated with forward-looking statements, noting that actual results may differ materially from expectations due to various factors, highlighting the challenges posed by the company's relatively limited operating history in evaluating its business prospects.
See More
Ibotta Reports Q1 Earnings, Revenue Beats Expectations
- Earnings Performance: Ibotta's Q1 GAAP EPS of -$0.43 misses expectations by $0.12, indicating challenges in profitability that may affect investor confidence.
- Revenue Results: The company reported Q1 revenue of $82.48 million, a 2.5% year-over-year decline, yet it beats market expectations by $1.76 million, suggesting some level of market demand despite difficulties.
- Financial Guidance: For Q2 2026, Ibotta projects revenue between $82 million and $86 million, reflecting a cautious outlook with a year-over-year decrease of 2% at the midpoint, indicating a careful approach to future market conditions.
- Adjusted EBITDA: The expected adjusted EBITDA ranges from $9 million to $12 million, with a midpoint margin of 12.5%, demonstrating the company's efforts in cost control despite overall revenue decline.
See More
Johnson Fistel Investigates Potential Claims Against Hasbro and Others for Fiduciary Breaches
- Hasbro Shareholder Investigation: Johnson Fistel is investigating potential claims against Hasbro (NASDAQ: HAS) executives, as shareholders who held shares before February 7, 2022, may seek corporate governance reforms aimed at enhancing executive oversight and recovering funds, highlighting concerns over corporate governance practices.
- Humana Financial Disclosures: Humana Inc. (NYSE: HUM) shareholders who held shares continuously since July 27, 2022, may pursue governance reforms due to executives allegedly downplaying the impact of rising medical costs on adjusted earnings per share, which poses risks of information asymmetry for investors.
- Ibotta IPO Risks: Ibotta (NYSE: IBTA) failed to disclose significant risks associated with its contract with Kroger during its April 18, 2024 IPO, exposing investors to undisclosed risks and potentially impacting its governance structure reforms.
- Inspire Medical Device Issues: Inspire Medical Systems (NYSE: INSP) shareholders who held shares before August 6, 2024, may seek governance reforms as executives allegedly failed to disclose that demand for the Inspire V device was weaker than expected, leading to a significant reduction in earnings guidance and raising questions about corporate transparency.
See More
Ibotta Extends Strategic Partnership with Denver Nuggets
- Community Investment Commitment: Ibotta's extended strategic partnership with the Denver Nuggets reflects the company's deep emotional ties and investment in the Denver community, further solidifying its influence in the local market.
- Sponsorship Agreement Extension: The partnership includes the sponsorship of the Nuggets' jersey patch, signifying that Ibotta's relationship with the team goes beyond commercial interests to a shared commitment to the city's development.
- Charitable Impact: The 'A Shot for Change' initiative launched in 2023 has raised over $250,000 for local nonprofits, demonstrating Ibotta's active role in supporting the community.
- Employee Engagement: Ibotta employees are actively involved in volunteer activities with the Nuggets, providing groceries for local students, which further strengthens the company's connection with the community.
See More
UBER ENTERS EXCLUSIVE MULTI-YEAR PARTNERSHIP WITH IBOTTA PERFORMANCE NETWORK
Uber's New Partnership: Uber has entered into a multi-year partnership with the IBOtta performance network.
Focus on Performance Marketing: The collaboration aims to enhance Uber's performance marketing strategies through IBOtta's platform.
See More
Ibotta Announces Additional $100 Million Stock Buyback
- Buyback Program Expansion: Ibotta's board has authorized an additional $100 million stock buyback of Class A common stock, building on a previous $300 million repurchase approval, reflecting the company's confidence in its stock value.
- Financial Strength: The strong balance sheet and consistent cash flow generation enable Ibotta to return capital to shareholders while continuing to invest in the Ibotta Performance Network, ensuring effective capital returns.
- No Expiration Limit: The stock repurchase program has no expiration date, allowing for flexible adjustments in timing and amounts based on market conditions and other factors, enhancing the company's capital management flexibility.
- Future Revenue Guidance: Ibotta outlines Q1 2026 revenue guidance of $78 million to $82 million, with transformation driven by LiveLift indicating a positive outlook for the company's growth prospects.
See More
Ibotta Authorizes $100 Million Stock Buyback
- Buyback Program Expansion: Ibotta's Board of Directors has authorized an additional $100 million for the repurchase of Class A common stock, building on a previous $300 million authorization, which reflects the Board's confidence in the company's long-term growth prospects.
- Capital Allocation Strategy: CEO Bryan Leach emphasized that this buyback reflects the company's commitment to a disciplined capital allocation strategy aimed at creating value for shareholders while maintaining a strong balance sheet and consistent cash flow generation.
- Flexible Repurchase Mechanism: The share repurchase program has no expiration date, allowing repurchases to be conducted through open market transactions or privately negotiated deals based on market conditions and legal requirements, ensuring the company can effectively buy back shares while adapting to market changes.
- Forward-Looking Statement Risks: Ibotta cautions investors about the risks and uncertainties associated with forward-looking statements, noting that actual results may differ materially from expectations due to various factors, highlighting the challenges posed by the company's relatively limited operating history in evaluating its business prospects.
See More
